TTF

(redirected from Thyroid Transcription Factor)
AcronymDefinition
TTFTrueType Font (file extension; Windows)
TTFTourism & Transport Forum (Australia)
TTFTask Technology Fit (information technology theory)
TTFThyroid Transcription Factor
TTFText to Fax
TTFTrue Type Font
TTFTimber Trade Federation
TTFTransportation Trust Fund
TTFTime-to-Treatment Failure (endpoint in clincial trials)
TTFThink Tank Fund (Open Society Foundations)
TTFTime to Failure
TTFTitle Transfer Facility (Dutch gas trading hub)
TTFTest and Training Facility (various locations)
TTFTaiwan Textile Federation
TTFTime to Fly
TTFTrident Training Facility
TTFTowards the Future (gaming)
TTFTransit Time Function
TTFTechnical Task Force
TTFTransition Task Force
TTFTrade & Transport Facilitation
TTFTime to Fire
TTFTerrorism Task Force
TTFTanker Task Force
TTFTechnical Trail Feature
TTFThe Tallini Family (micronation)
TTFTexas Teaching Fellows
TTFTechnology Transfer Fund
TTFTrend-Type Forecast
TTFTiny Triplet Finder
TTFThe Tolkien Forum
TTFTuna Tracking Form (US Dept of Commerce)
TTFTime to Forget
TTFTurkiye Tenis Federasyonu (Turkish Tennis Federation)
TTFTerminal Transaction Facility (IBM)
TTFTactical Task Force
TTFTT Fijnmechanica (Japanese company)
TTFThat's Too Funny
TTFTechTalk Forums
TTFTurbine Test Facility
TTFTexas Tourism Foundation
TTFTransient Time Flowmeter
TTFTask Transmittal Form
TTFThai Toilet Foundation
TTFTrainng Task Force (various locations)
TTFTemporary Test Facility
TTFThe Tequihua Foundation (volunteer corps; Riverside, CA; est. 2004)
References in periodicals archive ?
Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray.
Partial deficiency of thyroid transcription factor 1 produces predominantly neurological defects in humans and mice.
Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies.
A through F, The RNAscope assay results for thyroid transcription factor 1 expression in lung adenocarcinomas from 0 (negative) to [4.
Thyroid transcription factor 1 expression by immunohisto-chemical analysis was initially exclusively identified in thyroid and lung epithelial tissues, including normal, benign, and malignant tissues.
Numerous biomarkers have been studied and suggested as useful for that purpose, (1-68) such as cytokeratin (CK) 7, CK20, estrogen receptor (ER), gross cystic disease fluid protein 15 (GCDFP-15), mammaglobin (MGB), thyroid transcription factor 1 (TTF1), napsin A, caudal type homeobox 2 (CDX2), Wilms tumor 1 (WT1), OCT4 (octamer-binding transcription factor 4), and paired box gene (PAX) 8.
Thyroid transcription factor 1 (TTF1) and napsin A are routinely used in the diagnosis of ADC; they are found in 85% to 90% of ADC cases.
Napsin A is an aspartic protease of the pepsin family A whose expression is regulated in pulmonary epithelium by thyroid transcription factor 1 (TTF-1).
In addition, this group found that tumor immunoprofile had important clinicopathologic implications, with thyroid transcription factor 1 (TTF1) and [DELTA]Np63 null tumors demonstrating significantly worse patient outcomes.
Thus far, lung specific markers for SCC have been limited, whereas napsin A and thyroid transcription factor 1 (TTF-1) have proven to be useful in the diagnosis of primary lung ACAs.
Patterning of the "distal esophagus" in esophageal atresia with tracheoesophageal fistula: is thyroid transcription factor 1 a player?